Company
Headquarters: Singapore, Singapore
Employees: 294
CEO: Dr. Teck Liang Beng
S$192.1 Million
SGD as of Dec. 1, 2022
US$142.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services. The Diagnostic & Aesthetics Business segment provides radiology and diagnostic imaging services; refractive surgery services; dental services, including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery, and gum treatment; and aesthetics medicine services consisting of facial aesthetics, body aesthetics, facial and breast fillers, IPL, lasers, Botox, microdermabrasion minimally invasive Silhouette threadlift, VASER-assisted LipoSelection, and plastic surgery. The Others segment offers business consultancy and telemedicine services. It also offers breast related medical services; develops software/e-commerce applications for medical related services, as well as operates approximately 30 clinics. The company was incorporated in 2005 and is based in Singapore.
Singapore Medical Group Ltd has the following listings and related stock indices.
Stock: SGX: 5OT wb_incandescent